When to publish measures of disproportionality derived from spontaneous reporting databases?

Affiliations

Comment

Anthonius de Boer. Br J Clin Pharmacol. 2011 Dec.

. 2011 Dec;72(6):909-11.

doi: 10.1111/j.1365-2125.2011.04087.x.

¹ Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences, Utrecht, The Netherlands. a.deboer@uu.nl

No abstract available

Comment on

Memory disorders associated with consumption of drugs: updating through a case/noncase study in the French PharmacoVigilance Database.
Chavant F, Favrelière S, Lafay-Chebassier C, Plazanet C, Pérault-Pochat MC. Chavant F, et al. Br J Clin Pharmacol. 2011 Dec;72(6):898-904. doi: 10.1111/j.1365-2125.2011.04009.x. Br J Clin Pharmacol. 2011. PMID: 21557759 Free PMC article.

1. Chavant F, Favrelière S, Lafay-Chebassier C, Plzanet C, Pérault-Pochat MC. Memory disorders associated with drugs consumption: updating through a case/non-case study in the French PharmacoVigilance Database. Br J Clin Pharmacol. 2011 May 10. doi: 10.1111/j.1365-2125.2011.04009.x. [Epub ahead of print] - DOI - PMC - PubMed
1. Bate A, Evans SJW. Quantitative signal detection using spontaneous ADR reporting. Pharmacoepidemiol Drug Saf. 2009;18:427–36. - PubMed
1. Pariente A, Gregoire F, Fourrier-Reglat A, Haramburu F, Moore N. Impact of safety alerts on measures of disproportionality in spontaneous reporting databases. The notoriety bias. Drug Saf. 2007;30:891–8. - PubMed
1. Moore N, Thiessard F, Begaud B. The history of disproportionality measures (reporting odds ratio, proportional reporting rates) in spontaneous reporting of adverse drug reactions. Pharmacoepidemiol Drug Saf. 2005;14:285–6. - PubMed
1. Pariente A, Didailler M, Avillach P, Miremont-Salamé F, Moore N. A potential competition bias in the detection of safety signals from spontaneous reporting databases. Pharmacoepidemiol Drug Saf. 2010;19:1166–71. - PubMed